ask="N/A"
ask_size="N/A"
average_daily_volume="17808"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="-0.35"
change_from_200_day_moving_average="0.52"
change_from_50_day_moving_average="0.29"
change_from_52_week_high="-2.10"
change_From_52_week_low="2.75"
change_in_percent="-5.65%"
close="5.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.50"
eps_estimate_next_quarter="-0.11"
eps_estimate_next_year="-0.51"
ex_dividend_date="N/A"
float_shares="3450000"
high="6.20"
high_52_weeks="7.95"
last_trade_date="3/7/2017"
last_trade_price="5.85"
last_trade_size="2500"
last_trade_time="4:00pm"
low="5.85"
low_52_weeks="3.10"
market_capitalization="167.95M"
moving_average_200_day="5.33"
moving_average_50_day="5.56"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="8.38"
open="6.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+9.72%"
percent_change_from_50_day_moving_average="+5.20%"
percent_change_from_52_week_high="-26.42%"
percent_change_from_52_week_low="+88.71%"
previous_close="6.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="14.03"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="2.98"
stock_exchange="ASE"
symbol="OCX"
volume="146761"
weeks_range_52="3.10 - 7.95"
